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We studied the effect of two probiotic Bacillus subtilis strains on the growth performance, digestive
enzyme activity, immune gene expression and disease resistance of juvenile white shrimp (Litopenaeus
vannamei). A mixture of two probiotic strains, L10 and G1 in equal proportions, was administered at two
different doses 105 (BM5) and 108 (BM8) CFU g1 feed to shrimp for eight weeks. In comparison to
untreated control group, ﬁnal weight, weight gain and digestive enzyme activity were signiﬁcantly
greater in shrimp fed BM5 and BM8 diets. Signiﬁcant differences for speciﬁc growth rate (SGR) and
survival were recorded in shrimp fed BM8 diet as compared with the control; however, no signiﬁcant
differences were recorded for food conversion ratio (FCR) among all the experimental groups. Eight
weeks after the start of the feeding period, shrimp were challenged with Vibrio harveyi. Statistical
analysis revealed signiﬁcant differences in shrimp survival between probiotic and control groups.
Cumulative mortality of the control group was 63.3%, whereas cumulative mortality of the shrimp that
had been given probiotics was 20.0% with BM8 and 33.3% with BM5. Subsequently, real-time PCR was
employed to determine the mRNA levels of prophenoloxidase (proPO), peroxinectin (PE), lipopolysac-
charide- and b-1,3-glucan-binding protein (LGBP) and serine protein (SP). The expression of all immune-
related genes studied was signiﬁcantly up-regulated (P < 0.05) in the shrimp fed BM5 and BM8 diets
compared to the control group. These ﬁndings demonstrate that administration of B. subtilis strains, L10
and G1, can improve growth performance and disease resistance through an enhanced immune response
in shrimp.
 2012 Elsevier Ltd. Open access under CC BY-NC-ND license.1. Introduction
World aquaculture production has increased signiﬁcantly in the
last years [1]. Among them, shrimp farming is one of the fastest
growing aquaculture sectors in many tropical countries; however,
this development has been accompanied by adverse impacts due to
the intensiﬁcation, such as problems related to diseases and dete-
rioration of environmental conditions [2]. The occurrence of
infectious diseases in shrimp aquaculture is a serious problem due
to the overuse or misuse of antibiotics and antibiotic resistance
genes among opportunistic pathogens such as Vibrio species [3e5].
In addition, the invertebrate immune system is highly depends onþ60 3 8947 4949.
cheroos@agri.upm.edu.my
Y-NC-ND license.the innate mechanisms and in theory, is incapable of responding to
speciﬁc vaccines [6]. In fact, the development of vaccines for shrimp
infectious diseases have had limited success and limited informa-
tion has resulted from these studies [7]. Therefore, other alterna-
tives such as probiotic bacteria have been examined in order to
control the infectious diseases not only in shrimp aquaculture but
also in other farmed aquatic species [8]. A recent study has
demonstrated that dietary administration of an antagonistic
bacterium, Psychrobacter sp., improved the feed utilization, enzyme
activity and immune response of grouper, Epinephelus coioides [9].
Moreover, dietary administration of Lactobacillus plantarum resul-
ted in an enhanced immune response in white shrimp, Litopenaeus
vannamei [10] and rainbow trout, Oncorhynchus mykiss [11].
Application of Bacillus subtilis as probiotic has brought very
promising results for shrimp aquaculture. This bacterium is a non-
pathogenic Gram positive spore-forming which has been used to
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disease management [12e15]. In addition it is well documented
that Bacillus species are able to produce a wide range of extra-
cellular substances and antimicrobial peptides against variety of
microorganisms [16e19].
We have recently reported the isolation, identiﬁcation and
characterization of two B. subtilis strains, L10 and G1, with antag-
onistic ability against two shrimp pathogens, Vibrio harveyi and
Vibrio parahaemolyticus [20]. The aims of the current study was
thus to investigate whether a mixture containing two strains, L10
and G1, could improve the growth performance, digestive enzyme
activity, immune gene expression and disease resistance of juvenile
white shrimp (L. vannamei).
2. Materials and methods
2.1. Bacterial strains
B. subtilis strains L10 and G1, previously isolated and identiﬁed
from fermented pickles [20], were used as potential probiotics. A
virulent strain, V. harveyi ATCC 14126, was used for experimental
infection in this study. All strains were preserved at20 C in Luria-
Bertani broth (LB; Difco) with 15% sterile glycerol, prior to use.
2.2. Preparation of the feed
Probiotic B. subtilis strains, L10 and G1, were grown in LB broth
using a shaking incubator at 30 C for 48 h. The cultures were then
centrifuged at 3000 g for 10 min at 4 C and, after discarding the
supernatant, the pelleted bacteria were re-suspended and washed
three times in sterile Normal Saline Solution (NSS, 0.9% NaCl). The
cell densities of the suspensions were calculated using spectro-
photometer at 600 nm and also correlated to the colony-forming
unit (CFU) using the spread-plate technique. These suspensions
were kept at 4 C until used.
Commercial feed (BLANCA, Malaysia) was used as the basal diet
for the supplementation of probiotic strains. B. subtilis strains L10
and G1 were sprayed into the feed to give a ﬁnal concentration of
approximately 105 CFU g1 (L10, 5  104 and G1, 5  104 CFU g1),
named BM5 and 108 CFU g1 (L10, 5107 and G1, 5 107 CFU g1),
named BM8. The amount of the probiotic strains in the feed was
determined using the spread-plate technique. Brieﬂy 1 g of each
feed type was randomly sampled and serially 10-fold diluted in
phosphate-buffered saline solution (PBS; pH 7.2) and 100 ml of each
dilution was then spread on mannitol-egg yolk-polymyxin agar
(MYP agar, Difco, USA) in order to estimate the probiotic concen-
tration (CFU g1).
2.3. Shrimp and experimental conditions
Healthy juvenile shrimps were provided by the Marine Science
Research Station and Biology Field Station, UPM, Port Dickson,
Malaysia and the experiment was conducted at the same place.
Shrimp had not been exposed to shrimp diseases and were deemed
pathogen-free. One hundred juvenile shrimp were weighted,
randomly distributed in 6 tanks containing 500 l seawater, and
acclimatized for 3 days prior to the experiment.
One group served as the control and was fed un-supplemented
diet during the entire experimental period. The other two groups
were fed B. subtilis-supplemented diets at two different doses 105
and 108 CFU g1 feed until the end of the experiment. Experiment
was conducted in duplicate for 8 weeks and the feed preparation
procedure was done twice a week. Shrimps were fed their speciﬁc
diets three times a day at 5% of the body weight.2.4. Water supply and analysis
The water was directly supplied from the sea and it was treated
before use. After ﬁltration, the salinity was reduced to 20 ppt using
fresh water. The tanks were maintained under constant aeration
(DO, 5  0.5 mg l1), with a 50% water change twice a week,
ambient temperature of 28  1 C and pH of 7.3e8.2. Temperature,
DO and pH were measured using an YSI (Yellow Spring Inc.). Water
chemical parameters were measured spectrophotometrically once
a week using the HACH kit (product no: 2107569 for Nitrite,
2605345 for Nitrate, and 2653299 for Ammonia). During the
experiment the chemical parameters were recorded within the
acceptable ranges of nitrite-N (<0.01  0.001 mg l1), nitrate-N
(<4  1 mg l1), and ammonia-N (<1.1  0.1 mg l1).
2.5. Biometry and sampling for analysis
At the end of the experiment, the ﬁnal weight, survival rate,
weight gain, feed conversion ratio (FCR), and speciﬁc growth rate
(SGR) of different treatments were calculated according to Rob-
ertson et al. (2000); Felix and Sudharsan (2004) and Venkat et al.
(2004):
Weight gain ðg=shrimpÞ ¼ Final weight ðgÞ  Initial weight ðgÞ
Feed conversion ratio ðFCRÞ ¼Total Feed Given ðgÞ=
Weight Gain ðgÞ
Specific growth rate ðSGR; %=dayÞ
¼ ð½ln final wt ln initial wt=DaysÞ  100
Survival rate ð%Þ: ðFinal numbers =Initial numbersÞ  100
One shrimp from each replicate was randomly collected at
week 0, 4, and 8 of the experiment to estimate the Bacillus sp.
and Vibrio sp. levels in shrimp gastrointestinal tract (GIT). For
enzyme activity assays, 5 shrimp from each replicate were
randomly collected at the end of week 8 and the GIT of each
shrimp was removed aseptically and then immediately packed
and immersed in liquid nitrogen. Samples were kept in 80 C
until analysis. The same procedure with one shrimp from each
replicate was followed for immune-related gene expression
assays (see below).
2.6. Bacteriological analysis
In order to estimate the Bacillus sp. and Vibrio sp. levels in
shrimp GIT, the spread-plate technique was followed as mentioned
above. Shrimp were aseptically dissected using a sterile surgical
scissor and the GIT was removed and homogenized in a sterile glass
homogenizer with PBS. To ensure the colonization of B. subtilis in
shrimp GIT, at the end of week 8, DNA of 10 random colonies from
the plates within the acceptable range of colony counts
(30e300 CFU plate1) were extracted and identiﬁed using the PCR
ampliﬁcation of 595-bp fragment corresponding to an internal
portion of the ‘B. subtilis group’ 16S rRNA [21]. The Primers Bsub5F
(50-AAG TCG AGC GGA CAG ATGG-30) and Bsub3R (50-CCA GTT TCC
AAT GAC CCT CCCC-30) were used for the PCR ampliﬁcation. DNA
extraction was followed by the boiling technique. Brieﬂy, colonies
were aseptically removed and homogenized in 1.5 ml Eppendorf
tubes containing 1 ml sterile double distilled water (ddH2O). The
suspensionwas incubated inwater bath at 95 C for 15min. Cellular
debris were then pelleted using centrifugation on 13000 g for
10 min. 2 ml of the supernatant was applied to master mix kit,
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of PCR ampliﬁcation products was veriﬁed by 2.0% (w/v) agarose gel
electrophoresis stained with ethidium bromide for 2 h with 85 V,
and photographed under UV illumination. 100 bp ladders were
used as markers.2.7. Digestive enzyme analysis
The crude extract of the GIT was used to quantify the digestive
enzyme activity of shrimp in different treatments. The whole of the
GIT of one or two shrimp were dissected out, pooled, weighted and
homogenized with cold deionized water (1:10). The homogenate
was then centrifuged at 5000 g for 20 min at 4 C. The supernatant
was carefully separated and passed through 0.45 mm-pore-size
ﬁlters (Sartorius, Germany). Aliquots were made in 1.5 ml Eppen-
dorf tubes in triplicates and kept at 20 C to analyze different
enzymes.
The total protein activity was measured using bovine serum
albumin as standard according to [22]. Total protease activity was
assayed using casein as the substrate which reacts with Folin’s
reagent [23]. A calibration curve of absorbance at 440 nm was
prepared using tyrosine as standard. One unit of protease activity
was deﬁned as the number of micromoles of tyrosine released per
min per mg of protein at 37 C. Total amylase activity was deter-
mined according to Rick and Stegbauer [24] using 1% soluble starch
as substrate reacting with 3,5-dinitrosalicylic acid. A calibration
curve of absorbance at 550 nm was prepared using a standard
maltose solution. One unit of amylase activity was deﬁned as the
number of micromoles of maltose released per min per mg of
protein at 37 C.2.8. Experimental infection
After eight weeks of the feeding period, an experimental
infection was induced in shrimp with the pathogenic bacterium,
V. harveyi ATCC 14126. V. harveyi was grown overnight in LB
medium and the concentration was adjusted to 107 CFUml1 using
NSS as previously mentioned. A total of 30 shrimp in the intermolt
stage were collected from the treatment and control groups and
injected with 20 ml of the bacterial suspension into the third
abdominal segment resulting 106 CFU shrimp1. Immediately after
injection, shrimp were transferred into the 20 l tanks with 10
shrimp each. The experiment was conducted in triplicates and the
water was supplied from the previous tanks in order to minimize
the stress. A group of untreated shrimp with B. subtilis-supple-
mented diet, which was injected with NNS, served as positive
control (NB). During the experimental infection, shrimp were fed
their speciﬁc diets as previously described. The mortality was
monitored daily for up to 10 days.Table 1
Speciﬁc primers used to evaluate immune status of shrimp, Litopenaeus vannamei.
Gene Primer Seque
Prophenoloxidase ProPO-F GCCTT
ProPO-R CGCG
Peroxinectin PE-F TGGA
PE-R GACCG
Lipopolysaccharide and b-1,3-glucan-binding protein LGBP-F CATGT
LGBP-R ATCAC
Serine protein SP-F CGTCG
SP-R TTTCA
Housekeeping b-actin-F GAGC
b-actin-R CATCA2.9. Relative mRNA expression of immune-related genes
The expression of immune-related genes of shrimp following
the challenge with V. harveyi was determined by real-time RT-PCR
at 24 h post-injection. One shrimp from each replicate was
randomly collected for RNA extraction. Since it was almost
impossible to collect hemocytes from the shrimp (w3e4 g), the
whole body of shrimp was therefore freeze-dried using ample
amounts of liquid nitrogen and homogenized using RNase free
mortar and pestle. 100 mg of the homogenized was subjected for
RNA extraction and puriﬁcation using the guanidinium thiocyanate
method [25]. The reverse transcription was used to synthesize the
ﬁrst-strand cDNA using QuantiTect Rev. Transcription Kit (Qiagen)
containing the oligo-(dT)18. The manufacturer’s recommendations
were followed to maximize cDNA synthesis.
Four speciﬁc primers [10], and b-actin as the housekeeping gene
were used to determine immune-related gene expression. The
primer sequences and product sizes are presented in Table 1.
For real-time-PCR, the QuantiTect SYBR Green PCR master
mix kit (Qiagen) containing HotStarTaq DNA Polymerase, Quanti-
Tect SYBR Green PCR Buffer, dNTP mix, Fluorescent dyes (SYBR
Green I and ROX as the reference dye) and RNase-free water was
mixed with synthesized cDNA. The real-time-PCR thermal proﬁle
for all immune-related genes was at 95 C for 5 min followed by 40
cycles of 95 C for 10 s and 60 C for 30 s, according to manufac-
turer’s recommendation. Melting curves were generated by
ramping the temperature from 70 to 90 C in 2 s for each step
afterward. In order to obtain the efﬁciency, separately one standard
curve was generated for each gene using the same thermal proﬁle
as mentioned above. Ampliﬁcation of cDNA was performed using
the Rotor-Gene Q instrument (Qiagen). Each sample from the
treated and untreated shrimp was analyzed with four replicate.
The comparative quantitation analysis was performed by REST
software package version 2.0.13, 2009 [26] for group-wise
comparison and statistical analysis of real-time PCR data. REST
applies the efﬁciency-corrected comparative CP method and
performs randomization tests to estimate a sample’s expression
ratio and the likelihood of up or down-regulation, taking into
account the reference genes and the individual ampliﬁcation efﬁ-
ciency of each gene [27]. The relative expression ratios were
calculated by a mathematical model, which included an efﬁciency
correction for real-time PCR efﬁciency of the individual transcripts,
as follows:
Ratio ¼ Etarget
DCPtargetðcontrolsampleÞ
.
Eref
DCP
ref ðcontrolsampleÞ:
The relative expression ratio of a target gene was computed
based on its real-time PCR efﬁciencies (E) and the crossing pointnce (50e30) Product size (bp) References
GGCAACGCTTTCA 68 [44]
CATCAGTTCAGTTTGT
CCTCGCGGGAGAT 56 [45]
ATAGCCACCATGCTT
CCAACTTCGCTTTCAGA 64 [43]
CGCGTGGCATCTT
TTAGGTTAAGTGCGTTCT 61 [46]
GCGCATTAAGACGTGTT
AACACGGAGTTCGTTGT 68 GenBank accession
no: AF300705CCAACTGGGACGACATGGA
Table 3
Log mean of Bacillus spp. and Vibrio spp. count (cfu g1) in gastrointestinal tract of
shrimp Litopenaeus vannamei in different treatments and control during 55 days of
culture with Bacillus subtilis, strain L10 and G1.
Time
(week)
BM8: 108 cfu g1 BM5: 105 cfu g1 Control
Log Bacillus
spp. count
0 3.92  0.02a 3.92  0.02a 3.92  0.02a
4 5.19  0.05a 4.51  0.09b 3.89  0.02c
8 6.47  0.03a 5.86  0.03b 3.93  0.05c
Log Vibrio
spp. count
0 5.53  0.01a 5.53  0.01a 5.53  0.01a
4 5.17  0.06b 5.1  0.21b 5.92  0.2a
8 4.85  0.07b 5.18  0.1b 5.92  0.2a
Values (means SD) with different superscript in a row show signiﬁcant differences
(P < 0.05).
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gene, cDNA dilution curves were generated and used to calculate
the individual real-time PCR efﬁciencies (E ¼ 10[1/slope]) [26,28].
The hypothesis test performed 2000 random reallocations of
samples and control between the groups. Statistical differences
were signiﬁcant when P < 0.05.
Box plot graphs were generated using the REST software to
present the relative gene expression or up/down regulation of the
shrimp immune genes of treatments in comparison to control.
2.10. Statistical analysis
Data on growth parameters, enzyme activity, and bacteriological
analysis in digestive tract among treatments were analyzed by
using ANOVA and Duncan’s multiple range test was used to
determine the signiﬁcant variation (P< 0.05). All statistical analysis
was performed using SPSS, version 15 (SPSS Inc, Chicago, IL, USA).
3. Results
3.1. Growth performance
The effect of diets containing B. subtilis strains, L10 and G1, on
growth performance were established in this study. Analyzed data
on the growth performance of shrimp in different treatments and
control, including initial weight, ﬁnal weight, weight gain, SGR,
FCR, and survival rate are showed in Table 2. There were no
signiﬁcant differences for initial weight between treatments and
control at the start of the experiment. At the end of the experiment,
statistical analysis showed that shrimp fed BM8 and BM5 diets
grew signiﬁcantly faster than the control group. Final weight was
recorded signiﬁcantly different (P < 0.05) for BM8 (3.46  0.06 g)
and BM5 (3.39  0.11 g) compared to the control (2.49  0.13 g). In
addition signiﬁcant differences (P < 0.05) were recorded in weight
gain for BM8 (2.79  0.007 g) and BM5 (2.65  0.02 g) in
comparison with control (1.82  0.13 g). No signiﬁcant differences
(P > 0.05) were recorded in survival rate and SGR neither between
shrimp fed BM8 and BM5 diets nor between shrimp fed BM5 diet
and control. However, the survival rate and SGR in the shrimp fed
BM8 diet were signiﬁcantly different (P < 0.05) from those of the
control group. There was no signiﬁcant difference (P > 0.05) in FCR
among all the experimental groups (Table 2).
3.2. Bacteriological analysis
The levels of Bacillus spp. and Vibrio spp. counted at week 0, 4,
and 8 were analyzed and are shown in Table 3. There were signif-
icant differences (P < 0.05) for Bacillus spp. and Vibrio spp. counts
between treatment and control groups. The highest (P < 0.05)
Bacillus spp. counts on MYP agar at week 4 and 8 were recorded for
BM8 followed by BM5 and control. The population of Bacillus spp. in
the GIT of shrimp fed BM8 and BM5 diets increased through 8
weeks of culture from 3.92  0.02 to 6.47  0.03 and
Table 2
Data of growth performance and survival of Litopenaeus vannamei cultured with
probiotics Bacillus subtilis, strains L10 and G1.
Treatments BM8: 108 cfu g1 BM5: 105 cfu g1 Control
Initial weight (g) 0.67  0.06a 0.74  0.1a 0.67  0a
Final weight (g) 3.46  0.06a 3.39  0.11a 2.49  0.13b
Weight gain (g) 2.79  0.007a 2.65  0.02a 1.82  0.13b
SGR (%) 2.97  0.14a 2.77  0.27ab 2.38  0.09b
FCR 1.86  0.03a 1.85  0.02a 1.92  0.02a
Survival (%) 100  00a 95.5  6.36ab 86.5  2.12b
Values (means SD) with different superscript in a row show signiﬁcant differences
(P < 0.05).5.86  0.03 log CFU g1, respectively. In contrast, no increase of
Bacillus spp. concentration was observed in the control (Table 3). In
order to conﬁrm at the genus level, the yellow colonies counted on
MYP agar as Bacillus spp. [21] were randomly picked (n ¼ 10) and
subjected for DNA ampliﬁcation using speciﬁc primers. Out of the
10 colonies, 9 and 7 of them showed speciﬁc ampliﬁcation at
595 bp, which were isolated from shrimp fed BM8 and BM5 diets,
respectively (Fig. 1), whereas only 2 colonies were recorded to be
Bacillus spp. in the control (Fig. 1). The bacteriological analysis and
the molecular detection assay clearly showed that B. subtilis strains
L10 and G1 were able to colonize in the GIT after shrimp had
received the diet containing both strains for 8 weeks. In addition,
there were considerable reductions (P < 0.05) of Vibrio spp. in the
GIT of shrimp fed BM8 and BM5 diets at week 4 and 8. Compared to
the control, signiﬁcant differences (P < 0.05) in the reduction of
Vibrio spp. levels were observed through 8 weeks of experiment,
ranging from5.53 0.01 to 4.85 0.07 and 5.18 0.1 log CFU g1 in
the shrimp fed BM8 and BM5 diets, respectively (Table 3).
3.3. Total protein and enzymes activity
Total protein, protease and amylase activity showed highly
signiﬁcant differences (P< 0.05) among all the experimental groups
after 8 weeks of culture as summarized in Table 4. The highest
protein, protease and amylase activity (P < 0.05) was recorded for
theGITof shrimp fedBM8 followedbyBM5andcontrol, respectively.
Clearly B. subtilis strains L10 and G1 showed their ability to increase
digestive enzymeactivities and induce ahigher total protein content
in the GIT of shrimp fed BM8 and BM5 diets.
3.4. Mortality and immune-related gene expression
After 8 weeks of the feeding period, shrimp fed BM8 and BM5
diets and the control were infected with V. harveyi. CumulativeFig. 1. Bacillus spp. detection in gastrointestinal tract (GIT) of shrimp Litopenaeus
vannamei after 8 weeks of culture with or without probiotics B. subtilis, strains L10 and
G1. DNA ampliﬁcation of random colonies from shrimp GTI of; BM8: 108 cfu g1 (a),
BM5: 105 cfu g1 (b) NB: no addition of probiotic (c).
Table 4
Digestive enzyme activity of Litopenaeus vannamei in treatments and control after 55
days fed with or without Bacillus subtilis, strains L10 and G1.
Activity (U g1 protein) Treatments
BM8: 108 cfu g1 BM5: 105 cfu g1 Control
Total protein 3.45  0.11a 2.99  0.19b 2.43  0.1c
Protease 1.43  0.09a 1.31  0.03b 0.93  0.03c
Amylase 1.48  0.14a 1.19  0.13b 0.68  0.12c
Values (means SD) with different superscript in a row show signiﬁcant differences
(P < 0.05).
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Fig. 3. The mRNA expression of four immune genes of Litopenaeus vannamei fed with
Bacillus subtilis for 55 days and challenged with Vibrio harveyi. Gene expression proﬁle
of (a) shrimp fed B. subtilis L10 and G1 (108 cfu g1): proPo (P(H1) ¼ 0.019), PE
(P(H1) ¼ 0.011), LGBP (P(H1) ¼ 0.013), and SP (P(H1) ¼ 0.025) are UP-regulated
(P < 0.05) in sample group in comparison to control group, (b) shrimp fed B. subtilis
L10 and G1 (105 cfu g1): proPo (P(H1) ¼ 0.018), PE (P(H1) ¼ 0.019), LGBP
(P(H1) ¼ 0.011), and SP (P(H1) ¼ 0.021) are UP-regulated (P < 0.05) in sample group in
comparison to control group, (c) shrimp fed without probiotics but injected with
Normal Saline Solution: proPo (P(H1) ¼ 0.024), PE (P(H1) ¼ 0.025),
LGBP(P(H1) ¼ 0.016), and SP (P(H1) ¼ 0.031) are UP-regulated (P < 0.05) in sample
group in comparison to control group. Control group was fed without probiotics but
injected with V. harveyi. Data on the Boxplots represent the mean factors of gene
expresions compared to control group. P(H1) represent the hypothesis test (P < 0.05).
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(106 CFU shrimp1) of V. harveyi showed signiﬁcant differences
(P < 0.05) between BM8 (20  10%) and BM5 (33.3  5.7%)
compared to the control group (63.3  15.3%) (Fig. 2). No mortality
was observed in shrimp from the positive control which had been
injected with NSS.
The proPO gene was signiﬁcantly up-regulated (P < 0.05) in all
shrimp fed B. subtilis-supplemented diets compared to the control
group, with mean expression ratios of 48.77, 23.37 and 5.31 for
BM8, BM5 and NB, respectively. PE showed signiﬁcant up-
regulation (P < 0.05) ratios including 784.4 for BM8, 11.3 for BM5
and 6.63 for NB compared to the control group. Expression of LGBP
found to be signiﬁcantly up-regulated (P < 0.05) in comparison to
control with mean ratios of 24.83, 11.08 and 15.26 for BM8, BM5
and NB, respectively. In respond to pathogen V. harveyi, SP gene
expression of shrimp in BM8, BM5 and NB were recorded in
comparison to control, with signiﬁcant up-regulations (P < 0.05)
with mean ratios of 61.55, 28.34 and 11.33, respectively (Fig. 3).
4. Discussion
Manipulation of microbiota using probiotics have been reported
as a worthy practice for aquaculture in order to control or inhibit
the pathogen bacteria, improve the growth performances and
digestive enzymes, and enhance the immune responses of the host
against pathogens or physical stress [3,8,29]. We have recently re-
ported the identiﬁcation, characterization and safety of B. subtilis
strains L10 and G1 as potential probiotics for shrimp culture [20]. In
this study we determined the growth performance and digestive
enzyme activity of shrimp fed diets containing B. subtilis strains, L10
and G1, at two different doses of 105 (BM5) and 108 (BM8) CFU g1
feed. Survival and immune status of treated shrimp have also been
investigated through an experimental infection with V. harveyi.0
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Fig. 2. Cumulated mortality (%) of white shrimp, Litopenaeus vannamei, for 10 days
after being injected with Vibrio harveyi (106 cfu shrimp1) for BM8, BM5, and control or
injected with NSS for NB statistical analysis showed the highest mortality (P < 0.05) of
shrimp during 10 days of the challenge test for shrimp in control group compared to
those shrimp in BM8, BM5 and NB. Different letters at the point of each day reperesent
signiﬁcant differences (P < 0.05) among treatments. Bars reperesent the SD for each
point. (B) BM8: 108 cfu g1 (,) BM5: 105 cfu g1 () NB: no addition of probiotics but
injected with NSS (:) control: no addition of probiotics but injected with V. harvyi.Dietary administration of B. subtilis strains L10 and G1 signiﬁ-
cantly improved ﬁnal weight, weight gain, SGR and survival of
shrimp fed BM5 and BM8 diets (Table 2). Although several studies
have demonstrated the beneﬁcial effects of probiotics on the
growth performance in shrimp [13,30,31], the exact mechanism of
action is not well understood. The ﬁrst explanation could be related
to the action of competitive exclusion, by which probiotics may
create a hostile environment for pathogen colonization. This
mechanism of action has been determined in this study because of
the GITof treated shrimpwas dominated by successful colonization
of B. subtilis (Table 3). In addition, molecular detection of B. subtilis
fromMYP agar plates conﬁrmed the presence of strains L10 and G1
in the GIT of the treated shrimp. On the other hand, the consider-
able reduction of Vibrio spp. populations in the GIT of shrimp fed
BM5 and BM8 diets (Table 3) clearly showed the successful
competitive exclusion of B. subtilis strains L10 and G1.
Another possible explanation for the improvement of the
shrimp growth factors by B. subtilis may be due to the induction of
digestive enzymes, including protease and amylase, which conse-
quently stimulate the natural digestive enzyme activity of the host
H. Zokaeifar et al. / Fish & Shellﬁsh Immunology 33 (2012) 683e689688[30,31]. In this study, the higher level of total digestive enzyme
activity was recorded in shrimp fed B. subtilis-supplemented diets
where the better growth performances were observed compared to
control. Similar results have been reported by Ziaei-Nejad et al. [32]
who observed a higher digestive enzyme activity in shrimp (Fen-
neropenaeus indicus) treated with Bacillus spp. than the controls.
In addition, it is important to mention that a better appetite was
observed in shrimp feddiets containingB. subtilis L10 andG1 than the
control group during the feeding period because of undigested feed
residues were not found. A better feed digestionmay be related to an
increase of the digestive enzyme activity and subsequently increased
the appetite in treated shrimp. Therefore by taking into accountof the
enzyme activity and appetite stimulation, together with the coloni-
zation of B. subtilis in the GIT of shrimp fed BM8 and BM5 diets,
healthier shrimp and higher survival rate of 100 and 95.5% were
resulted, respectively, compared to control with 86.5% (Table 2).
Eight weeks after the start of the feeding period, shrimp were
challenged with pathogenic bacterium V. harveyi. As Fig. 2 shows,
a higher resistance was observed in shrimp fed diets containing
B. subtilis strains L10 and G1. A signiﬁcantly lower mortality was
recorded in shrimp fed BM8 and BM5 diets compared to the control
group.
It is well known that hemocytes play important roles in the host
immune responses. They are responsible for cellular defense
mechanisms and also releasing humoral defensemolecules in order
to protect the body toward microbial intruders [33]. For the present
study, it was almost impossible to collect hemocytes from juvenile
shrimp (w3e4 g) to analyze the immune responses and biological
activities such as pro-phenoloxidase activity (PO), phagocytosis
activity, respiratory burst, cell adhesion activity, clearance efﬁ-
ciency, and superoxidase dismutase activity. Therefore, the
expression of four immune-related genes was investigated using
the real-time PCR in order to evaluate the immune status of shrimp
after being injected with V. harveyi or NSS.
Activation of the prophenoloxidase-activating system is through
recognition molecules in the hemolymph of invertebrates [34]. The
prophenoloxidase activating system is a non-self-recognition
system in invertebrates that is able to recognize and respond to
intruders via lipopolysaccharides or peptidoglycan from bacteria
and b-1,3-glucans from fungi [34]. Chiu et al. [10] reported that up-
regulation of proPO resulted in increased PO activity in shrimp fed
L. plantarum-supplemented diet, which enhanced the resistance
against the pathogen, Vibrio alginolyticus. Similar results were
found in our study, where up-regulation of proPO was recorded in
shrimp fed BM8 and BM5 diets compared to the control group after
challenge with V. harveyi. Chiu et al. [10] also suggested that the
expression of PE gene can increase the biological activity of cell
adhesion [35,36], opsonin [37], degranulation [38], peroxidase [39],
and encapsulation [40] of shrimp. These biological activities might
be achieved in the present study with the administration of
B. subtilis strains L10 and G1, as PE gene up-regulation was
enhanced in treated shrimp compared to the control.
Serine protein (SP) is responsible for converting proPO to PO
[34]. The proPO gene expression in shrimp fed diets containing
B. subtilis was accompanied with the up-regulation of SP gene for
the same group of shrimp, suggesting that the up-regulation of
proPO gene was a consequence of the gene expression of SP.
Different result for SP regulation was observed by Liu et al. [41],
although the gene expression of proPO was enhanced in shrimp
treated with B. subtilis E20. Compared to the present study, it could
be due to the period of their experiment which had been 2 weeks
according to their study.
Lipopolysaccharide- and b-1,3-glucan-binding protein (LGBP) is
well knownasanotherkeyof the immuneresponsewhich recognizes
and responds to microbial intruders and results in the activation ofproPO system [42]. Cheng et al. [43] revealed that LGBP has a crucial
role in shrimp defense during the early stage. They found the up-
regulation of LGBP gene in the hepatopancreas of L. vannamei, 24 h
post-injection with V. alginolyticus. These ﬁndings are comparable
with the up-regulation of LGBP gene extracted at 24 h post-injection
from shrimp fed diets containing B. subtilis strains L10 and G1. These
facts suggest that the up-regulation and gene expression of proPO
might be a consequence of LGBP up-regulation for treated shrimp
with B. subtilis L10 and G1 as probiotics.
The manipulation of shrimp intestinal microbiota using
B. subtilis strains, L10 and G1, induced the expression of immune-
related genes and a better protection against V. harveyi. The four
immune-related genes tested in this study including proph-
enoloxidase (proPO), the cell adhesive protein, peroxinectin (PE),
the recognition protein, lipopolysaccharide- and b-1,3-glucan-
binding protein (LGBP), and serine protein (SP) which are relative to
the proPO system showed up-regulation of these genes in shrimp
fed diets containing B. subtilis strains L10 and G1. These ﬁndings are
in agreement with the increase of the biological activities in treated
shrimp, resulting in a higher survival rate after challenge with
V. harveyi. It can be kept in mind that the expression of immune-
related genes and a higher survival rate in treated shrimp may be
also due to the competitive exclusion, higher digestive enzyme
activity, and better growth performance.
In conclusion, administration of B. subtilis strains L10 and G1
improved the growth performances, digestive enzyme activity and
immune response against the pathogenic bacterium, V. harveyi. In
addition, a better survival rate was obtained in shrimp fed probiotic
diets after challenge with V. harveyi.Acknowledgement
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